Built for her biology,
not his marketing.
The evidence-based, non-commercial guide to supplements and claims marketed at women.
Prenatal
The category with the strongest possible evidence for one ingredient (folic acid), a genuine open debate for a second (methylfolate), and a nutrient most prenatals quietly shortchange (choline).
The typical choline content in standard prenatal multivitamins — well short of the 450mg/day target for pregnancy, because choline is bulky and expensive to include at full dose in a multivitamin tablet.
Not a clear 'her' win either way — this is one case on this page where the popular marketing claim (methylfolate is better) actually outruns the evidence for the outcome that matters most.
What it is, and why people take it
Prenatal vitamins are formulated for pregnancy's increased demand for specific nutrients: folate to prevent neural tube defects in early fetal development, iron to support the roughly 50% increase in maternal blood volume, choline for fetal brain and spinal cord development, and DHA for fetal brain and eye development.
They're typically started before conception when possible, since neural tube closure happens by week 6, often before pregnancy is confirmed.
Why this happens
Folic acid has the strongest evidence base of nearly anything on this page: large randomized trials from the early 1990s established that 400mcg–800mcg of folic acid daily, started before conception, cuts neural tube defect risk substantially — this is the evidence that led to mandatory food fortification in dozens of countries. Methylfolate (5-MTHF) is marketed as superior, particularly for the estimated 30-60% of women with MTHFR gene variants that reduce folic acid conversion. Recent randomized trials confirm methylfolate maintains folate status while producing less 'unmetabolized folic acid' in the blood — a real, measurable difference. But no randomized trial has directly tested methylfolate against folic acid for the outcome that actually matters — neural tube defect prevention — and one such trial would be considered unethical to run, since it would mean withholding folic acid's proven benefit from half the participants. So the honest state of the evidence: folic acid has decades of outcome data; methylfolate has good biomarker data but no head-to-head outcome trial. Either is a reasonable choice; treat 'methylfolate is scientifically superior' marketing claims with some skepticism.
Important: the 2026 Frontiers RCT on methylfolate was funded by Ritual, a prenatal vitamin brand. The authors are legitimately university-affiliated (Brooklyn College CUNY, Cornell), but this is manufacturer-funded research, not an independent comparison — treat the methylfolate findings with that in mind. (No specific brand is recommended in this category's buy-guide on the basis of this study.)Choline is the clearer miss. A randomized trial found prenatal choline supplementation measurably improved how the body uses supplemental DHA, working through a specific metabolic pathway (PEMT) that's especially active in pregnancy. Most standard prenatals simply don't include enough to matter, which is a formulation choice, not a scientific one — choline is bulky, so a multivitamin can't fit a full 450mg dose into one reasonably-sized pill alongside everything else.
DHA is worth a candid note too: despite heavy marketing around fetal brain development, a Cochrane review and multiple large randomized trials found DHA supplementation has little consistent effect on child cognitive outcomes specifically, though it may modestly reduce preterm birth risk. It's not wasted, but the 'smarter baby' framing oversells what the trials actually show.
What to look for instead
- Start before conception if possible — neural tube closure happens by around week 6, often before a pregnancy test is positive.
- Either folate form is a reasonable choice at 400–800mcg — don't let methylfolate marketing talk you out of a well-formulated folic-acid prenatal, or vice versa.
- Check the choline number specifically — most standard prenatals need a separate choline supplement to reach 450mg; this is the nutrient most worth double-checking on the label.
- Avoid vitamin A as retinol above 10,000 IU — look for beta-carotene form instead, since high-dose retinol carries birth defect risk.
- This category more than any other needs your OB or midwife in the loop — individual factors (MTHFR status, existing anemia, multiples) change what's right for you specifically.
A note on age
Not applicable in the usual sense here — this category is inherently about pregnancy and preconception. What matters more than age is timing: starting before conception is what the neural-tube-defect evidence is actually built on.
Where to buy
What buying the best-seller implies
The standard, most widely used OTC prenatal (#1 OB/GYN-recommended OTC brand). Solid folic acid, DHA, and iron coverage.
What the evidence actually shows
Essentially no choline, like most prenatals in this price tier.
Most popular pick
Evidence-based for women
Same trusted line, but adds a dedicated choline tablet — 110mg, still under the 450mg target, but meaningfully more than the 0–55mg in most standard prenatals.
Cost breakdown
The same per-serving prices, at a day.
Switching from the most popular pick to an evidence-based one costs about $2.10 more a month.
Sources 4 studies · show list
- Draicchio, Hausser, Sharafi, Grier-Welch, Vance, Alamdari, Futterman, Chudnoff, Malysheva, Caudill, Hanson, Jiang (2026). Using 6S-5-methyltetrahydrofolate instead of folic acid in prenatal multivitamin reduces unmetabolized folic acid concentrations: 24-week RCT. Frontiers in Nutrition. PMC13062212
- Cochrane, Elango, Devlin, Mayer, Hutcheon, Karakochuk (2024). Supplementation with (6S)-5-methyltetrahydrofolic acid appears as effective as folic acid in maintaining maternal folate status. British Journal of Nutrition. PubMed 37649241
- Klatt, McDougall, Malysheva, Taesuwan, Loinard-González, Nevins, Beckman, Bhawal, Anderson, Zhang, Bender, Jackson, King, Dyer, Devapatla, Vidavalur, Brenna, Caudill (2022). Prenatal choline supplementation improves biomarkers of maternal DHA status among pregnant participants: RCT. American Journal of Clinical Nutrition. PMC9437984
- Fleming, Rosa, Bland, Kauwell, Malysheva, Wettstein, Hausman, Bailey, Park (2024). Response of One-Carbon Biomarkers in Maternal and Cord Blood to Folic Acid Dose During Pregnancy. Nutrients. PMC11547940